Skip to main content

What the FDA labels say about taking them together

Atorvastatin and drospirenone/ethinyl estradiol

Drospirenone/ethinyl estradiol's FDA label of May 29, 2025 names atorvastatin in its drug interactions section; the atorvastatin labels PlainMeds reads (2) do not name drospirenone/ethinyl estradiol. The drospirenone/ethinyl estradiol label: “Substances increasing the plasma concentrations of COCs: Co-administration of atorvastatin and certain COCs containing EE increase AUC values for EE by approximately 20%.”

Check it at the source: the atorvastatin FDA label on DailyMed (effective April 15, 2024, Viatris Specialty LLC); the drospirenone/ethinyl estradiol FDA label on DailyMed (effective May 29, 2025, Bayer HealthCare Pharmaceuticals Inc.).

What does the atorvastatin label say about drospirenone/ethinyl estradiol?

Atorvastatin's label (effective April 15, 2024) and its 1 other brand-application label do not name drospirenone/ethinyl estradiol in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Lipitor), NDA020702 (Upjohn), as published by Viatris Specialty LLC, effective April 15, 2024 (SPL set a60cc18b-0631-4cf0-b021-9f52224ece65), via openFDA; the full label on DailyMed

What does the drospirenone/ethinyl estradiol label say about atorvastatin?

Drospirenone/ethinyl estradiol label, drug interactions

Substances increasing the plasma concentrations of COCs: Co-administration of atorvastatin and certain COCs containing EE increase AUC values for EE by approximately 20%.

Source: FDA drug label (Yaz), Bayer HealthCare Pharmaceuticals Inc., effective May 29, 2025 (SPL set 065f33e4-b587-4e66-b896-ca9ab7b7c876), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

59Atorvastatin generic labelers
15Drospirenone/ethinyl estradiol generic labelers
AtorvastatinDrospirenone/ethinyl estradiol
Labeled forHigh cholesterol, Angina, High triglycerides, Heart attack and coronary artery diseaseAcne, Birth control
Boxed warningNoYes
Pharmacy cost (NADAC)$0.0228 per tablet 10 mg tablet$0.151 per tablet 3-0.03 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?